Critical Analysis: Halozyme Therapeutics


Halozyme Therapeutics and Proteon Therapeutics are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations. This is a summary of recent ratings and target prices for Halozyme Therapeutics and Proteon Therapeutics, as reported by MarketBeat.



from Biotech News